11-06-2026 17:00 via nytimes.com

With Measles Roaring Back, the Search for a Drug is On

As vaccination rates decline, biotech companies see a potential new market for measles drugs.
Read more »

Biotechnology news



After 2 Plasma Donor Deaths, Company Pauses Clinics in Canada
Prediction Market Betting on Drug Trials and Approvals Sparks Concern About Undermining Research
Chemical actuation expands the design space of living light materials
Mary-Dell Chilton Dies at 87; Helped Create First Genetically Modified Plant
Programmable mycolysins expand the antimicrobial toolkit against mycobacteria
The New Race to Find Treatments for Measles
Better Sex, Better Hair, Better Sleep: ‘Humanmaxxing’ Is Here
As Ebola Spreads in East Africa, Will China Step Up?
J. Craig Venter (1946—2026)
China’s Rise in Drug Development Looms Over U.S.
Reprogramming halophilic life for low-salt biomanufacturing
Biotechnologies based on the fungal bioluminescence pathway
Blue at the edge
The Rich and Powerful Want to Live Forever
Desktop versie